c-Met inhibitor JNJ-38877605

{
  "id": "MLC-T-ONC-012670",
  "term": "c-Met inhibitor JNJ-38877605",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antineoplastic activity. c-Met inhibitor JNJ-38877605 selectively inhibits c-Met, a receptor tyrosine kinase (RTK) involved in cancer cell survival and invasiveness, and tumor angiogenesis. c-Met is also known as hepatocyte growth factor receptor (HGFR).",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/c-met-inhibitor-jnj-38877605/"
}